Molecular Targeting Probes - Radioactive & Nonradioactive -> Preclinical Probes for Cardiovascular, Endocrine & Other 453a

453a - Theranostic spleen targeting H2S donating liposome for immune modulation (ID 1351)

Session Name
Preclinical Probes for Cardiovascular (Poster Session II)
Speakers
Authors
Presentation Topic
Molecular Targeting Probes - Radioactive & Nonradioactive -> Preclinical Probes for Cardiovascular, Endocrine & Other
Presentation Number
453a

Previous Eposter
453 - Improving the test-retest repeatability of MBF quantification for Rb-82 PET. (ID 1203)

Next Eposters
454 - Comparison of processing methods for 18F-florbetapir PET amyloid quantification (ID 861)
455 - Early peak equilibrium is superior to late pseudo-equilibrium for simplified quantification of 18F-FE-PE2I PET (ID 862)
457 - Evaluation of the novel 18F-labeled PET tracer SMBT-1 for imaging astrogliosis in Alzheimer's disease (ID 863)
458 - Preliminary Evidence for [11C]PBR28 Sensitivity to Alcohol Challenge in Human Brain (ID 865)
462 - First-in-Human study of [18F]SynVesT-2, a novel SV2A radioligand with fast kinetics and high specific binding signals (ID 867)
464 - Validation of multidose vial preparation fill line within F-18 Fludeoxyglucose manufacturing. (ID 338)
465 - Optimization of [68Ga] Production via Cyclotron Irradiation 1.0 M Zn(NO3)2 solution for the Synthesis of [Ga-68] PSMA-11 HBED. (ID 344)
466 - Validating Cyclotron-Produced 68Ga as an Alternative Source for Compounding Radiopharmaceutical Kits (ID 337)
468 - Production of [89Zr]Oxinate4 and cell labeling for human use (ID 343)
469 - Improved synthesis of [18F]fluoro-d2-methyl tosylate suitable for automated pharmaceutical labeling (ID 342)